Our work

Ending the obesity epidemic

Obesity remains a major public health challenge in the UK, but opportunities could be harnessed to reverse current trends.

Transforming lung cancer care

HPP worked with the International Association for the Study of Lung Cancer (IASLC) to identify opportunities for policy action to improve the lives of people with lung cancer.

Immunisation for people living with non-communicable diseases

Immunisation against common respiratory infections is a crucial tool for reducing the burden of NCDs.

Patient navigation for lung cancer: an essential component of care

Chronic respiratory diseases

Chronic respiratory diseases, which affect the airways and lungs, impede the lives of over 454 million people worldwide.

Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom

This qualitative paper from HPP and the Batten Disease Family Association explores the devastating impact of Batten disease, a rare group of inherited neurodegenerative disorders that mostly arise in childhood.

Building environmental considerations into the evaluation of health interventions

HPP worked with the Sustainable Healthcare Coalition to develop a discussion paper on building environmental consideration into the evaluation of health interventions.

National calls to action for radioligand therapy

Radioligand therapy is a targeted treatment with huge potential to improve cancer care around the world; HPP collaborated with experts to identify key barriers to implementing radioligand therapy and co-developed recommendations to overcome these challenges.

Late diagnosis in cancer sparks outrage – so why not heart failure?

Ahead of forthcoming national cardiovascular strategies, this article highlights the need to recognise the societal cost of delayed diagnosis in heart failure.